Juliane Zielonka
Born in Bielefeld, she studied German, English and psychology. The emergence of the Internet in the early '90s led her from university to training in graphic design and marketing communications. After years of agency work in corporate branding, she switched to publishing and learned her editorial craft at Hubert Burda Media.
She discovered the world of the stock market in 1998. With her passion for innovation and digitalization, she focused on companies from the technology and healthcare sectors early on.
Analyzing fundamentals, business models and their scalability is as much her passion as thinking into complex future scenarios. Since 2019, she has regularly organized stock exchange roundtables and attended international investment events to deepen and pass on her knowledge.
Commented by Juliane Zielonka
Commented by Juliane Zielonka on May 17th, 2022 | 11:56 CEST
With a focus on Asia: Well positioned with Hong Lai Huat, BYD & Alibaba shares
In volatile stock market times, investors win with a smartly positioned portfolio. That includes tangible assets such as real estate, renewable energy in the form of electric cars as the engine of the future, and generally looking to the Asian market for trading platforms such as Alibaba, the biggest top dog alongside Amazon. In countries like Cambodia, with an inflation rate of 2-3%, the economy is booming. Real estate companies like Hong Lai Huat are also focusing on acquiring agricultural land. We look at which stable value assets are optimal to invest in during times of Corona.
Read
Commented by Juliane Zielonka on May 12th, 2022 | 13:07 CEST
Cardiol Therapeutics, Tesla, Bayer AG - Instead of trading chronically overvalued shares, treat the chronically ill instead
No sooner does the US government under Biden seek to influence the Supreme Court in the Monsanto case than the Bayer share slides 7%. But is this share price slide justified? Bayer AG has made provisions for the possible ruling in June and set aside reserves for chronic diseases. Chronic diseases are also a focus of Cardiol Therapeutics. According to the World Health Organization (WHO), the prevalence of chronic diseases increased by 57% worldwide by 2020. Cardiol focuses on heart health in this regard. The share stands at about EUR 1.12 and is seen by analysts at an average of about EUR 7. Meanwhile, Tesla investors are currently experiencing what overvalued shares can do to their portfolios. Their CEO is speculating that he will no longer accept new customers. Why? You can read about it here...
Read
Commented by Juliane Zielonka on May 10th, 2022 | 12:38 CEST
Biotech stocks: Defence Therapeutics, BioNTech, BASF - Advantage through platform technology
Large corporations such as BASF were previously considered safe portfolio investments. But the war in Ukraine is throwing a spanner in the works. Force majeure, such as war, can cause deals to fall through without the responsibility of the companies involved. How should investors react now? Which portfolio strategy can keep up with the high volatility of the markets? Newcomers like BioNTech face oversupply and have to accept shortages. A focus on emerging markets seems to be the solution for their growth strategy. But there are subtle differences in the vaccines business, as Defence Therapeutics proves.
Read
Commented by Juliane Zielonka on May 5th, 2022 | 12:57 CEST
Bayer, NervGen, Adler Group - Pharma and Real Estate, management in focus
Corporate giant Bayer is collaborating with Charité Berlin to cure genetic diseases in the future. A paradox? Big Pharma thrives on alleviating symptoms but not curing diseases. Things will soon look different. The biotech company NervGen is also dedicated to curing diseases. The approach here: reverse degenerative nerve conditions through self-healing. Specifically, this means helping individuals with paraplegia who are wheelchair-bound reconnect their neural pathways. The Company is in the clinical trials phase and was started by a co-founder who witnessed a dramatic accident. One cannot speak of an accident at the real estate company Adler Group. Four board members have resigned after auditor KPMG refused to give its OK for the annual financial statements. Can management regain the confidence of shareholders?
Read
Commented by Juliane Zielonka on May 3rd, 2022 | 13:18 CEST
Adler Group, Amazon, Almonty - Free fall and strong growth
Investing in real estate is becoming increasingly volatile, whether as a landlord due to higher energy prices or as an investor in the Adler Group. In the latter case, auditor KPMG did not put an audit certificate on the 2021 annual financial statements because it remains unclear how the loss of around EUR 1 billion came about. The share slid into the basement, and four board members resigned. A look across the pond at Amazon, and Amazon Web Services, in particular, shows what can help a balanced portfolio mix. Boeing, the Seattle-based company, has gained a significant customer in the aviation industry. In this industry, the rare earth metal tungsten is in great demand. Thanks to its high density, it protects against radiation and is used for this purpose in the sheathing of aircraft. We take a look at what investors should watch out for now.
Read
Commented by Juliane Zielonka on April 28th, 2022 | 12:04 CEST
Mercedes-Benz, Edison Lithium, K+S - Strong gains from the start
Mercedes-Benz AG scores with a good return on cars and vans in the first quarter of this year. Luxury and electric, in particular, are selling like hotcakes. Despite the pandemic, delivery problems and the lapsed Russian business, shareholders are benefiting from the current share price. To meet the demand for electromobility, areas with mineral resources such as lithium and cobalt are becoming increasingly valuable. These metals are used in batteries to power electric vehicles. The fertilizer company K+S is also providing drive in the agricultural sector. With its products, farmers generate almost twice as much crop yield. However, this disturbs a delicate balance, prompting the German Federal Ministry of Research and Education to take action.
Read
Commented by Juliane Zielonka on April 21st, 2022 | 13:58 CEST
Bayer AG, Perimeter Medical, Twitter - Shareholder interests drive share price performance
The life science and medical technology sectors offer investment opportunities. Whether with old hands like Bayer AG or up-and-coming innovative startups like Perimeter Medical, each company has its own fascination. Strong corporate management that acts in the interests of shareholders provides additional confidence. The latter, in particular, is currently being put to the test at the short messaging service Twitter. Elon Musk's takeover bid threatens to dilute existing investors' shares with a poison pill.
Read
Commented by Juliane Zielonka on April 15th, 2022 | 12:01 CEST
mm2 Asia, Nvidia, Bayer AG - Digital marketplaces with high scalability
Shanghai is currently experiencing the totalitarian proportions of a zero-COVID strategy. Due to soaring cases, 26 million people have to go into a harsh lockdown. After more than two years of the pandemic, the images from the Chinese metropolis seem all the more disturbing. Helplessness is spreading. People are tired of the inhumane measures. Those who test positive have to spend their quarantine in specially equipped hospitals, separated from their families and other foreign positives. The dystopian experiences of the Corona Pandemic, which everyone has personally experienced in recent months, provide an unexpectedly timely stage for arguably the most spectacular re-mastering and launch on April 21 of an Asian indie film classic in the psychological thriller genre.
Read
Commented by Juliane Zielonka on April 7th, 2022 | 14:30 CEST
Phoenix Copper, Nordex, Tesla - Gold rush mood at the beginning of the supply chain
If the EU turns off the gas tap from Russia, alternatives are needed quickly to keep Germany running as a business location. With its wind turbines, Nordex SE is facing cybersecurity challenges, and Tesla shareholders are looking anxiously at the antics of their CEO, who is putting on yet another corporate hat. Producers are reeling from supply chain disruptions and other unreliabilities these days. So it is good to know there are reliable companies at the top of the supply chain: Phoenix Copper, with its raw material deposits of copper, gold and zinc, is not only an explorer on the hunt for the best mineral resources but also a collector.
Read
Commented by Juliane Zielonka on March 31st, 2022 | 11:21 CEST
Kodiak Copper, Plug Power, BYD - Copper, copper and more copper
Carmaker BYD is finally showing itself without a mask: the brand-new Ocean X model is giving rival Tesla a run for its money. The Chinese electric carmaker is thus tapping into the design-savvy target group in the upper-middle class, which is climate-neutral and cost-conscious and relies on timeless elegance. Powered by electric motors with 203 hp, anyone will then be able to overtake the plug-powered MAN trucks in the left lane from 2023. But only if explorers like Kodiak Copper continue to successfully discover copper areas to meet market demand for the popular metal. 'Teamwork makes the dream work' is especially true for the Canadian Company's top executives.
Read